Phosphatidylserine Comprehensive Study by Application (Dietary Supplement, Functional Foods, Medical Foods, Others), Source (Meat, Fish, Plants), Nature (Organic, Conventional), Form (Powder, Liquid, Capsule), Distribution Channel (Hypermarket, Supermarket, Specialty store, Online) Players and Region - Global Market Outlook to 2030

Phosphatidylserine Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Phosphatidylserine
Phosphatidylserine is an amino acid derivative compound similar to a dietary fat which is highly prevalent in human neural tissue. Typically it is white or light yellow loose powder but also a small amount of phosphatidylserine is liquid. It is vital for cognitive function. Phosphatidylserine is high in neutral oil and fatty acids and produced in low purity that has an off-flavor to it. Phosphatidylserine supplementation in older individuals seems to improve memory and cognitive capacity.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Chinese Vendors will contribute the maximum growth to Global Phosphatidylserine market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Chemi Nutra (United States), Lipoid (Switzerland ), Novastell (France), Lonza Group (Switzerland), Sino Herb (China), H&C pharmaceutical (CSHPHARM) (Switzerland), Guanjie Biotech (China) and L&P Food Ingredient (China) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Phosphatidylserine market by , Application (Dietary Supplement, Functional Foods, Medical Foods and Others) and Region.



On the basis of geography, the market of Phosphatidylserine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Source , the sub-segment i.e. Meat will boost the Phosphatidylserine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Nature, the sub-segment i.e. Organic will boost the Phosphatidylserine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Powder will boost the Phosphatidylserine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hypermarket will boost the Phosphatidylserine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Adoption of Plant-Based Products Creating

Market Growth Drivers:
Increasing Demand for Functional Foods and Dietary Supplements and Rising Health Consciousness among Population

Challenges:
Fluicatuion in the Price of Raw Material

Restraints:
Government Regulation

Opportunities:
Manufacturers Focused on Innovating New Products by Incorporating Phosphatidylserine and Growth in the Cosmetic Industry

In February 2021, Lipogen (Haifa, Israel) launched CognoLipid, a phospholipid formula combining phosphatidylserine (PS) and phosphatidic acid (PA) for the support of cognitive performance1 and chronic stress2. The formula is vegan, FDA GRAS, and allergen-free.


Key Target Audience
Phosphatidylserine Manufacturers, Phosphatidylserine Suppliers/Distributors, End-User Industry and Potential Investors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Dietary Supplement
  • Functional Foods
  • Medical Foods
  • Others
By Source
  • Meat
  • Fish
  • Plants

By Nature
  • Organic
  • Conventional

By Form
  • Powder
  • Liquid
  • Capsule

By Distribution Channel
  • Hypermarket
  • Supermarket
  • Specialty store
  • Online

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Functional Foods and Dietary Supplements
      • 3.2.2. Rising Health Consciousness among Population
    • 3.3. Market Challenges
      • 3.3.1. Fluicatuion in the Price of Raw Material
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Plant-Based Products Creating
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Phosphatidylserine, by Application, Source , Nature, Form, Distribution Channel and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Phosphatidylserine (Value)
      • 5.2.1. Global Phosphatidylserine by: Application (Value)
        • 5.2.1.1. Dietary Supplement
        • 5.2.1.2. Functional Foods
        • 5.2.1.3. Medical Foods
        • 5.2.1.4. Others
      • 5.2.2. Global Phosphatidylserine by: Nature (Value)
        • 5.2.2.1. Organic
        • 5.2.2.2. Conventional
      • 5.2.3. Global Phosphatidylserine by: Form (Value)
        • 5.2.3.1. Powder
        • 5.2.3.2. Liquid
        • 5.2.3.3. Capsule
      • 5.2.4. Global Phosphatidylserine by: Distribution Channel (Value)
        • 5.2.4.1. Hypermarket
        • 5.2.4.2. Supermarket
        • 5.2.4.3. Specialty store
        • 5.2.4.4. Online
      • 5.2.5. Global Phosphatidylserine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Phosphatidylserine (Price)
  • 6. Phosphatidylserine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Chemi Nutra (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Lipoid (Switzerland )
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novastell (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Lonza Group (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sino Herb (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. H&C pharmaceutical (CSHPHARM) (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Guanjie Biotech (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. L&P Food Ingredient (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Phosphatidylserine Sale, by Application, Source , Nature, Form, Distribution Channel and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Phosphatidylserine (Value)
      • 7.2.1. Global Phosphatidylserine by: Application (Value)
        • 7.2.1.1. Dietary Supplement
        • 7.2.1.2. Functional Foods
        • 7.2.1.3. Medical Foods
        • 7.2.1.4. Others
      • 7.2.2. Global Phosphatidylserine by: Nature (Value)
        • 7.2.2.1. Organic
        • 7.2.2.2. Conventional
      • 7.2.3. Global Phosphatidylserine by: Form (Value)
        • 7.2.3.1. Powder
        • 7.2.3.2. Liquid
        • 7.2.3.3. Capsule
      • 7.2.4. Global Phosphatidylserine by: Distribution Channel (Value)
        • 7.2.4.1. Hypermarket
        • 7.2.4.2. Supermarket
        • 7.2.4.3. Specialty store
        • 7.2.4.4. Online
      • 7.2.5. Global Phosphatidylserine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Phosphatidylserine (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Phosphatidylserine: by Application(USD Million)
  • Table 2. Phosphatidylserine Dietary Supplement , by Region USD Million (2018-2023)
  • Table 3. Phosphatidylserine Functional Foods , by Region USD Million (2018-2023)
  • Table 4. Phosphatidylserine Medical Foods , by Region USD Million (2018-2023)
  • Table 5. Phosphatidylserine Others , by Region USD Million (2018-2023)
  • Table 6. Phosphatidylserine: by Nature(USD Million)
  • Table 7. Phosphatidylserine Organic , by Region USD Million (2018-2023)
  • Table 8. Phosphatidylserine Conventional , by Region USD Million (2018-2023)
  • Table 9. Phosphatidylserine: by Form(USD Million)
  • Table 10. Phosphatidylserine Powder , by Region USD Million (2018-2023)
  • Table 11. Phosphatidylserine Liquid , by Region USD Million (2018-2023)
  • Table 12. Phosphatidylserine Capsule , by Region USD Million (2018-2023)
  • Table 13. Phosphatidylserine: by Distribution Channel(USD Million)
  • Table 14. Phosphatidylserine Hypermarket , by Region USD Million (2018-2023)
  • Table 15. Phosphatidylserine Supermarket , by Region USD Million (2018-2023)
  • Table 16. Phosphatidylserine Specialty store , by Region USD Million (2018-2023)
  • Table 17. Phosphatidylserine Online , by Region USD Million (2018-2023)
  • Table 18. South America Phosphatidylserine, by Country USD Million (2018-2023)
  • Table 19. South America Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 20. South America Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 21. South America Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 22. South America Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 23. South America Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 24. Brazil Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 25. Brazil Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 26. Brazil Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 27. Brazil Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 28. Brazil Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 29. Argentina Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 30. Argentina Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 31. Argentina Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 32. Argentina Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 33. Argentina Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 34. Rest of South America Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 36. Rest of South America Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 37. Rest of South America Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 38. Rest of South America Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 39. Asia Pacific Phosphatidylserine, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 41. Asia Pacific Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 42. Asia Pacific Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 43. Asia Pacific Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 44. Asia Pacific Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 45. China Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 46. China Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 47. China Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 48. China Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 49. China Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 50. Japan Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 51. Japan Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 52. Japan Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 53. Japan Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 54. Japan Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 55. India Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 56. India Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 57. India Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 58. India Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 59. India Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 60. South Korea Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 61. South Korea Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 62. South Korea Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 63. South Korea Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 64. South Korea Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 65. Australia Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 66. Australia Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 67. Australia Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 68. Australia Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 69. Australia Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 75. Europe Phosphatidylserine, by Country USD Million (2018-2023)
  • Table 76. Europe Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 77. Europe Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 78. Europe Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 79. Europe Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 80. Europe Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 81. Germany Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 82. Germany Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 83. Germany Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 84. Germany Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 85. Germany Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 86. France Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 87. France Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 88. France Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 89. France Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 90. France Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 91. Italy Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 92. Italy Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 93. Italy Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 94. Italy Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 95. Italy Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 96. United Kingdom Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 97. United Kingdom Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 98. United Kingdom Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 99. United Kingdom Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 100. United Kingdom Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 101. Netherlands Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 102. Netherlands Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 103. Netherlands Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 104. Netherlands Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 105. Netherlands Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 106. Rest of Europe Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 107. Rest of Europe Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 108. Rest of Europe Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 109. Rest of Europe Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 110. Rest of Europe Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 111. MEA Phosphatidylserine, by Country USD Million (2018-2023)
  • Table 112. MEA Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 113. MEA Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 114. MEA Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 115. MEA Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 116. MEA Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 117. Middle East Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 118. Middle East Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 119. Middle East Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 120. Middle East Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 121. Middle East Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 122. Africa Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 123. Africa Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 124. Africa Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 125. Africa Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 126. Africa Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 127. North America Phosphatidylserine, by Country USD Million (2018-2023)
  • Table 128. North America Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 129. North America Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 130. North America Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 131. North America Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 132. North America Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 133. United States Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 134. United States Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 135. United States Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 136. United States Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 137. United States Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 138. Canada Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 139. Canada Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 140. Canada Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 141. Canada Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 142. Canada Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 143. Mexico Phosphatidylserine, by Application USD Million (2018-2023)
  • Table 144. Mexico Phosphatidylserine, by Source USD Million (2018-2023)
  • Table 145. Mexico Phosphatidylserine, by Nature USD Million (2018-2023)
  • Table 146. Mexico Phosphatidylserine, by Form USD Million (2018-2023)
  • Table 147. Mexico Phosphatidylserine, by Distribution Channel USD Million (2018-2023)
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Phosphatidylserine: by Application(USD Million)
  • Table 157. Phosphatidylserine Dietary Supplement , by Region USD Million (2025-2030)
  • Table 158. Phosphatidylserine Functional Foods , by Region USD Million (2025-2030)
  • Table 159. Phosphatidylserine Medical Foods , by Region USD Million (2025-2030)
  • Table 160. Phosphatidylserine Others , by Region USD Million (2025-2030)
  • Table 161. Phosphatidylserine: by Nature(USD Million)
  • Table 162. Phosphatidylserine Organic , by Region USD Million (2025-2030)
  • Table 163. Phosphatidylserine Conventional , by Region USD Million (2025-2030)
  • Table 164. Phosphatidylserine: by Form(USD Million)
  • Table 165. Phosphatidylserine Powder , by Region USD Million (2025-2030)
  • Table 166. Phosphatidylserine Liquid , by Region USD Million (2025-2030)
  • Table 167. Phosphatidylserine Capsule , by Region USD Million (2025-2030)
  • Table 168. Phosphatidylserine: by Distribution Channel(USD Million)
  • Table 169. Phosphatidylserine Hypermarket , by Region USD Million (2025-2030)
  • Table 170. Phosphatidylserine Supermarket , by Region USD Million (2025-2030)
  • Table 171. Phosphatidylserine Specialty store , by Region USD Million (2025-2030)
  • Table 172. Phosphatidylserine Online , by Region USD Million (2025-2030)
  • Table 173. South America Phosphatidylserine, by Country USD Million (2025-2030)
  • Table 174. South America Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 175. South America Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 176. South America Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 177. South America Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 178. South America Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 179. Brazil Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 180. Brazil Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 181. Brazil Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 182. Brazil Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 183. Brazil Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 184. Argentina Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 185. Argentina Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 186. Argentina Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 187. Argentina Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 188. Argentina Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 189. Rest of South America Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 190. Rest of South America Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 191. Rest of South America Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 192. Rest of South America Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 193. Rest of South America Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 194. Asia Pacific Phosphatidylserine, by Country USD Million (2025-2030)
  • Table 195. Asia Pacific Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 196. Asia Pacific Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 197. Asia Pacific Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 198. Asia Pacific Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 199. Asia Pacific Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 200. China Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 201. China Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 202. China Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 203. China Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 204. China Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 205. Japan Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 206. Japan Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 207. Japan Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 208. Japan Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 209. Japan Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 210. India Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 211. India Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 212. India Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 213. India Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 214. India Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 215. South Korea Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 216. South Korea Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 217. South Korea Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 218. South Korea Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 219. South Korea Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 220. Australia Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 221. Australia Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 222. Australia Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 223. Australia Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 224. Australia Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 225. Rest of Asia-Pacific Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 226. Rest of Asia-Pacific Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 227. Rest of Asia-Pacific Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 228. Rest of Asia-Pacific Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 229. Rest of Asia-Pacific Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 230. Europe Phosphatidylserine, by Country USD Million (2025-2030)
  • Table 231. Europe Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 232. Europe Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 233. Europe Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 234. Europe Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 235. Europe Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 236. Germany Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 237. Germany Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 238. Germany Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 239. Germany Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 240. Germany Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 241. France Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 242. France Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 243. France Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 244. France Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 245. France Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 246. Italy Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 247. Italy Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 248. Italy Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 249. Italy Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 250. Italy Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 251. United Kingdom Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 252. United Kingdom Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 253. United Kingdom Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 254. United Kingdom Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 255. United Kingdom Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 256. Netherlands Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 257. Netherlands Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 258. Netherlands Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 259. Netherlands Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 260. Netherlands Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 261. Rest of Europe Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 262. Rest of Europe Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 263. Rest of Europe Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 264. Rest of Europe Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 265. Rest of Europe Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 266. MEA Phosphatidylserine, by Country USD Million (2025-2030)
  • Table 267. MEA Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 268. MEA Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 269. MEA Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 270. MEA Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 271. MEA Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 272. Middle East Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 273. Middle East Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 274. Middle East Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 275. Middle East Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 276. Middle East Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 277. Africa Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 278. Africa Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 279. Africa Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 280. Africa Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 281. Africa Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 282. North America Phosphatidylserine, by Country USD Million (2025-2030)
  • Table 283. North America Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 284. North America Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 285. North America Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 286. North America Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 287. North America Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 288. United States Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 289. United States Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 290. United States Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 291. United States Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 292. United States Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 293. Canada Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 294. Canada Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 295. Canada Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 296. Canada Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 297. Canada Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 298. Mexico Phosphatidylserine, by Application USD Million (2025-2030)
  • Table 299. Mexico Phosphatidylserine, by Source USD Million (2025-2030)
  • Table 300. Mexico Phosphatidylserine, by Nature USD Million (2025-2030)
  • Table 301. Mexico Phosphatidylserine, by Form USD Million (2025-2030)
  • Table 302. Mexico Phosphatidylserine, by Distribution Channel USD Million (2025-2030)
  • Table 303. Research Programs/Design for This Report
  • Table 304. Key Data Information from Secondary Sources
  • Table 305. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Phosphatidylserine: by Application USD Million (2018-2023)
  • Figure 5. Global Phosphatidylserine: by Nature USD Million (2018-2023)
  • Figure 6. Global Phosphatidylserine: by Form USD Million (2018-2023)
  • Figure 7. Global Phosphatidylserine: by Distribution Channel USD Million (2018-2023)
  • Figure 8. South America Phosphatidylserine Share (%), by Country
  • Figure 9. Asia Pacific Phosphatidylserine Share (%), by Country
  • Figure 10. Europe Phosphatidylserine Share (%), by Country
  • Figure 11. MEA Phosphatidylserine Share (%), by Country
  • Figure 12. North America Phosphatidylserine Share (%), by Country
  • Figure 13. Global Phosphatidylserine share by Players 2023 (%)
  • Figure 14. Global Phosphatidylserine share by Players (Top 3) 2023(%)
  • Figure 15. Global Phosphatidylserine share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Chemi Nutra (United States) Revenue, Net Income and Gross profit
  • Figure 18. Chemi Nutra (United States) Revenue: by Geography 2023
  • Figure 19. Lipoid (Switzerland ) Revenue, Net Income and Gross profit
  • Figure 20. Lipoid (Switzerland ) Revenue: by Geography 2023
  • Figure 21. Novastell (France) Revenue, Net Income and Gross profit
  • Figure 22. Novastell (France) Revenue: by Geography 2023
  • Figure 23. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Lonza Group (Switzerland) Revenue: by Geography 2023
  • Figure 25. Sino Herb (China) Revenue, Net Income and Gross profit
  • Figure 26. Sino Herb (China) Revenue: by Geography 2023
  • Figure 27. H&C pharmaceutical (CSHPHARM) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. H&C pharmaceutical (CSHPHARM) (Switzerland) Revenue: by Geography 2023
  • Figure 29. Guanjie Biotech (China) Revenue, Net Income and Gross profit
  • Figure 30. Guanjie Biotech (China) Revenue: by Geography 2023
  • Figure 31. L&P Food Ingredient (China) Revenue, Net Income and Gross profit
  • Figure 32. L&P Food Ingredient (China) Revenue: by Geography 2023
  • Figure 33. Global Phosphatidylserine: by Application USD Million (2025-2030)
  • Figure 34. Global Phosphatidylserine: by Nature USD Million (2025-2030)
  • Figure 35. Global Phosphatidylserine: by Form USD Million (2025-2030)
  • Figure 36. Global Phosphatidylserine: by Distribution Channel USD Million (2025-2030)
  • Figure 37. South America Phosphatidylserine Share (%), by Country
  • Figure 38. Asia Pacific Phosphatidylserine Share (%), by Country
  • Figure 39. Europe Phosphatidylserine Share (%), by Country
  • Figure 40. MEA Phosphatidylserine Share (%), by Country
  • Figure 41. North America Phosphatidylserine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Chemi Nutra (United States)
  • Lipoid (Switzerland )
  • Novastell (France)
  • Lonza Group (Switzerland)
  • Sino Herb (China)
  • H&C pharmaceutical (CSHPHARM) (Switzerland)
  • Guanjie Biotech (China)
  • L&P Food Ingredient (China)
Select User Access Type

Key Highlights of Report


Mar 2024 214 Pages 92 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Chemi Nutra (United States), Lipoid (Switzerland ), Novastell (France), Lonza Group (Switzerland), Sino Herb (China), H&C pharmaceutical (CSHPHARM) (Switzerland), Guanjie Biotech (China) and L&P Food Ingredient (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Adoption of Plant-Based Products Creating" is seen as one of major influencing trends for Phosphatidylserine Market during projected period 2023-2030.
The Phosphatidylserine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Phosphatidylserine Report?